Europe drug regulator wins appeal over release of trial dataBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f7341 (Published 06 December 2013) Cite this as: BMJ 2013;347:f7341
- Zosia Kmietowicz
The European Union’s highest court has overturned a decision by a lower court that stopped the European drug regulator releasing clinical trial data it holds on two drugs.
The US drug company AbbVie and the Californian biotechnology company InterMune will now have to present new evidence to the lower court, the General Court of the European Union, to back up their claim that releasing information about their drugs to interested parties would cause them “serious and irreparable harm.”
The European Medicines Agency heard on 5 December that the European Court of Justice annulled previous rulings that stopped it releasing information it held …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial